1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsNIDCR supports mentored research training and career development of individuals with research or clinical doctoral degrees proposing basic, behavioral, translational and/or patient-oriented research, analysis and discoveries that advance dental, oral and craniofacial health.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Individuals with research or clinical doctoral degrees. NIDCR prioritizes funding for postdoctoral fellows, non-tenured early career faculty and clinician scientists. Confirm the full requirements in the official notice before applying.
Clinical Scientist Research Career Development Award (K08) is funded by National Institute of Dental and Craniofacial Research (NIDCR) / National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NIH National Institute of Dental and Craniofacial Research (NIDCR) Extramural Research Programs is sponsored by National Institute of Dental and Craniofacial Research (NIDCR) / National Institutes of Health (NIH). NIDCR supports basic, translational, and clinical research in dental, oral, and craniofacial health and disease through grants and cooperative agreements. This includes research on orofacial pain, odontogenic diseases, oral microbiome, oral cancer, developmental biology, computational biology, dental repair, regenerative medicine, immunomodulatory oral science, precision medicine, clinical trials, patient health, epidemiology, oral and systemic health integration, salivary gland biology, rheumatic disease, and behavioral interventions.
Advancing Imaging, Device Production, and Clinical Capabilities in Digital Dentistry (R41/R42 Clinical Trial Not Allowed) is sponsored by National Institute of Dental and Craniofacial Research (NIDCR) / National Institutes of Health (NIH). This Funding Opportunity Announcement (FOA) encourages innovation, optimization and customization of core technologies in digital dentistry that improve efficiency of oral healthcare delivery, effectiveness of clinical decision-making and outcomes of treatments associated with d…
Research on Etiological and Pathophysiological Mechanisms Underlying a Set of Chronic, Comorbid Conditions Associated with Temporomandibular Joint and Muscle Disorders (TMJMDs) (R03 Clinical Trial Not Allowed) is sponsored by National Institute of Dental and Craniofacial Research (NIDCR) / National Institutes of Health (NIH). Research on Etiological and Pathophysiological Mechanisms Underlying a Set of Chronic, Comorbid Conditions Associated with Temporomandibular Joint and Muscle Disorders (TMJMDs) (R03 Clinical Trial Not Allowed) is sponsored by National Institute of Dental and Craniofacial Researc…
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article